Wilkins; Tracy Dale

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wilkins; Tracy Dale.The latest application filed is for "method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease".

Company Profile

0.7.7

Wilkins; Tracy Dale - Riner VA
Wilkins; Tracy Dale - Blacksburg VA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease Grant 7,892,762 - Boone , et al. February 22, 2	2011-02-22
Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel Grant 7,785,818 - Boone , et al. August 31, 2	2010-08-31
Method for distinguishing ulcerative colitis from Crohn's disease by detecting the presence of fecal anit-neutrophil cytoplasmic antibodies (ANCA) Grant 7,736,858 - Boone , et al. June 15, 2	2010-06-15
Method For Diagnosing Irritable Bowel Syndrome and Monitoring Inflammatory Bowel Disease App 20090253155 - BOONE; JAMES HUNTER ; et al.	2009-10-08
Method for monitoring gastrointestinal inflammation in persons with inflammatory bowel disease(IBD) Grant 7,560,240 - Boone , et al. July 14, 2	2009-07-14
Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker Grant 7,192,724 - Boone , et al. March 20, 2	2007-03-20
Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae App 20050136495 - Boone, James Hunter ; et al.	2005-06-23
Method for measuring FceRII/CD23 IgE receptor in human feces as an indicator of a TH2 predominant immune response involved in gastrointestinal illnesses App 20050084910 - Boone, James Hunter ; et al.	2005-04-21
Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae Grant 6,872,540 - Boone , et al. March 29, 2	2005-03-29
Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel App 20040137536 - Boone, James Hunter ; et al.	2004-07-15
Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (ANCA) App 20040126898 - Boone, James Hunter ; et al.	2004-07-01
Method for differentiating irritable bowel syndrome from inflammatory bowel disease (IBD) and for monitoring persons with IBD using total endogenous lactoferrin as a marker App 20040033537 - Boone, James Hunter ; et al.	2004-02-19
Method and apparatus for distinguishing crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to saccharomyces cerevisiae App 20030143649 - Boone, James Hunter ; et al.	2003-07-31
Anaerobic microbe transport assembly and method of using Grant 3,939,044 - Wilkins , et al. February 17, 1	1976-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.